NCT02338349
- Conditions
- Advanced ER+, HER2-Negative Breast Cancer
- Locations
-
- Radius Pharmaceuticals, Inc. Waltham, Massachusetts, United States
Clinical trial condition
Advanced ER+, HER2-Negative Breast Cancer
Explore clinical trials studying Advanced ER+, HER2-Negative Breast Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies